GSK (GSK) issues statement Zantac (ranitidine) litigation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. LFTO
2. CMCSA
3. QNT
4. NVDA
5. VRDN
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to GSK (GSK) issues statement Zantac (ranitidine) litigation
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 52.81 +0.31 (0.59%)
Previous Close $52.50    52 Week High $45.58 
Open $52.48    52 Week Low $37.82 
Day High $52.93    P/E N/A 
Day Low $52.11    EPS $0.00 
Volume 4,183,346